Tag: TNF inhibitors
TNF Inhibitors and TB Reactivation: Screening and Monitoring Protocols
TNF inhibitors like adalimumab and infliximab effectively treat autoimmune diseases but carry a significant risk of reactivating latent tuberculosis. Proper screening, treatment of latent TB, and ongoing monitoring are essential to prevent life-threatening complications.
- January 18 2026
- Tony Newman
- 0 Comments